| Momordica charantia polysaccharides could protect against cerebral ischemia/reperfusion injury through inhibiting oxidative stress mediated c-Jun N-terminal kinase 3 signaling … J Gong, F Sun, Y Li, X Zhou, Z Duan, F Duan, L Zhao, H Chen, S Qi, ... Neuropharmacology 91, 123-134, 2015 | 113 | 2015 |
| HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation T Duan, Z Xu, F Sun, Y Wang, J Zhang, C Luo, M Wang Biomedicine & Pharmacotherapy 117, 109121, 2019 | 60 | 2019 |
| A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma T Wang, F Sun, W Xie, M Tang, H He, X Jia, X Tian, M Wang, J Zhang Cancer letters 372 (2), 166-178, 2016 | 55 | 2016 |
| Anti-CD24 antibody–nitric oxide conjugate selectively and potently suppresses hepatic carcinoma F Sun, Y Wang, X Luo, Z Ma, Y Xu, X Zhang, T Lv, Y Zhang, M Wang, ... Cancer research 79 (13), 3395-3405, 2019 | 51 | 2019 |
| CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy Y Han, F Sun, X Zhang, T Wang, J Jiang, J Cai, Q Gao, K Hezam, Y Liu, ... Journal of cancer research and clinical oncology 145, 1179-1190, 2019 | 41 | 2019 |
| FOXM1 regulates glycolysis and energy production in multiple myeloma Y Cheng, F Sun, K Thornton, X Jing, J Dong, G Yun, M Pisano, F Zhan, ... Oncogene 41 (32), 3899-3911, 2022 | 33 | 2022 |
| Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo Z Ma, H He, F Sun, Y Xu, X Huang, Y Ma, H Zhao, Y Wang, M Wang, ... Journal of Cancer Research and Clinical Oncology 143, 1929-1940, 2017 | 32 | 2017 |
| Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design F Sun, T Wang, J Jiang, Y Wang, Z Ma, Z Li, Y Han, M Pan, J Cai, M Wang, ... Oncotarget 8 (31), 51238, 2017 | 30 | 2017 |
| Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer Z Li, Y Zhu, C Li, R Trinh, X Ren, F Sun, Y Wang, P Shang, T Wang, ... Oncoimmunology 6 (3), e1290038, 2017 | 28 | 2017 |
| VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer X Wei, F Liu, Y Wang, X Ren, T Wang, Z Chen, M Tang, F Sun, Z Li, ... Oncotarget 7 (13), 16445, 2016 | 22 | 2016 |
| Autonomic nervous system control of multiple myeloma Y Cheng, F Sun, A D'Souza, B Dhakal, M Pisano, S Chhabra, M Stolley, ... Blood reviews 46, 100741, 2021 | 20 | 2021 |
| Artemin promotes oncogenicity, metastasis and drug resistance in cancer cells K Hezam, J Jiang, F Sun, X Zhang, J Zhang Reviews in the Neurosciences 29 (1), 93-98, 2018 | 20 | 2018 |
| Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy Y Zhang, M Pisano, N Li, G Tan, F Sun, Y Cheng, Y Zhang, X Cui Cellular Signalling 78, 109872, 2021 | 18 | 2021 |
| Germline risk contribution to genomic instability in multiple myeloma S Janz, F Zhan, F Sun, Y Cheng, M Pisano, Y Yang, H Goldschmidt, ... Frontiers in genetics 10, 424, 2019 | 18 | 2019 |
| NKG2D immunoligand rG7S-MICA enhances NK cell-mediated immunosurveillance in colorectal carcinoma T Wang, F Sun, Y Wang, J Jiang, M Pan, M Yuan, H Zhang, X Du, ... Journal of Immunotherapy 41 (3), 109-117, 2018 | 16 | 2018 |
| CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation D Gai, JR Chen, JP Stewart, I Nookaew, H Habelhah, C Ashby, F Sun, ... The Journal of clinical investigation 132 (18), 2022 | 15 | 2022 |
| The two novel DLL4-targeting antibody-drug conjugates MvM03 and MGD03 show potent anti-tumour activity in breast cancer xenograft models S Wang, R Zhou, F Sun, R Li, M Wang, M Wu Cancer Letters 409, 125-136, 2017 | 12 | 2017 |
| αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade M Pan, F Wang, L Nan, S Yang, J Qi, J Xie, S Shao, H Zou, M Wang, ... Cancer Immunology, Immunotherapy 72 (4), 969-984, 2023 | 11 | 2023 |
| Baicalin regulates autophagy to interfere with small intestinal acute graft-versus-host disease X Sun, M Pisano, L Xu, F Sun, J Xu, W Zheng, X Liu, Y Zhang, R Sun, ... Scientific Reports 12 (1), 6551, 2022 | 11 | 2022 |
| Neuroprotection of paclitaxel against cerebral ischemia/reperfusion-induced brain injury through JNK3 signaling pathway SH Qi, H Zhao, JJ Gong, FM Sun, J Yue, QH Guan, M Wang Journal of Receptors and Signal Transduction 31 (6), 402-407, 2011 | 10 | 2011 |
